Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Diamantopoulos

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 6, 2007
Neoadjuvant chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy for larynx preservation in patients with advanced laryngeal cancerC Andreadis, C Iliopoulou, T Sidiras, et al.
Clinical Genitourinary Cancer|March 18, 2020
Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the LiteratureLeonidas N Diamantopoulos, Ali R Khaki, Guru P Sonpavde, et al.
Urologic Oncology|March 17, 2023
Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinomaLeonidas N Diamantopoulos, Dimitrios Makrakis, Dimitrios Korentzelos, et al.
Human Pathology|October 17, 2022
ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institutionDimitrios Korentzelos, Esther Elishaev, Chengquan Zhao, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial CarcinomaAriel A Nelson, Robert J Cronk, Emily A Lemke, et al.
Bladder Cancer (Amsterdam, Netherlands)|June 10, 2021
Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomesLeonidas N Diamantopoulos, Ali Raza Khaki, Petros Grivas, et al.
Clinical Genitourinary Cancer|December 8, 2022
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial CarcinomaDimitrios Makrakis, Dimitra Rafailia Bakaloudi, Rafee Talukder, et al.
BJU International|April 28, 2021
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaborationPraful Ravi, Gregory R Pond, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|September 12, 2024
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort StudyDimitra Rafailia Bakaloudi, Elizabeth L Koehne, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|November 8, 2020
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) ProgramLeonidas N Diamantopoulos, Sarah K Holt, Ali R Khaki, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 6, 2007
Neoadjuvant chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy for larynx preservation in patients with advanced laryngeal cancerC Andreadis, C Iliopoulou, T Sidiras, et al.
Clinical Genitourinary Cancer|March 18, 2020
Central Nervous System Metastasis in Patients With Urothelial Carcinoma: Institutional Experience and a Comprehensive Review of the LiteratureLeonidas N Diamantopoulos, Ali R Khaki, Guru P Sonpavde, et al.
Urologic Oncology|March 17, 2023
Development and validation of a prognostic nomogram for overall and disease-specific survival in patients with sarcomatoid urothelial carcinomaLeonidas N Diamantopoulos, Dimitrios Makrakis, Dimitrios Korentzelos, et al.
Human Pathology|October 17, 2022
ARID1A, BRG1, and INI1 deficiency in undifferentiated and dedifferentiated endometrial carcinoma: a clinicopathologic, immunohistochemical, and next-generation sequencing analysis of a case series from a single institutionDimitrios Korentzelos, Esther Elishaev, Chengquan Zhao, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Early Bone Metastases are Associated with Worse Outcomes in Metastatic Urothelial CarcinomaAriel A Nelson, Robert J Cronk, Emily A Lemke, et al.
Bladder Cancer (Amsterdam, Netherlands)|June 10, 2021
Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomesLeonidas N Diamantopoulos, Ali Raza Khaki, Petros Grivas, et al.
Clinical Genitourinary Cancer|December 8, 2022
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial CarcinomaDimitrios Makrakis, Dimitra Rafailia Bakaloudi, Rafee Talukder, et al.
BJU International|April 28, 2021
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaborationPraful Ravi, Gregory R Pond, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|September 12, 2024
Small Cell Bladder Cancer: Treatment Patterns for Local Disease and Associated Outcomes. A Retrospective Cohort StudyDimitra Rafailia Bakaloudi, Elizabeth L Koehne, Leonidas N Diamantopoulos, et al.
Clinical Genitourinary Cancer|November 8, 2020
Response to Neoadjuvant Chemotherapy and Survival in Micropapillary Urothelial Carcinoma: Data From a Tertiary Referral Center and the Surveillance, Epidemiology, and End Results (SEER) ProgramLeonidas N Diamantopoulos, Sarah K Holt, Ali R Khaki, et al.
Pageof 4